Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma

Clinical Biochemistry

Volumn 40, Issue 13-14, 2007, Pages 1077-1080

  Murayama, Hiroshi ^a   Fukuda, Yoshihiro ^b   Tsunekawa, Shoji ^c   Ikemoto, Masaki ^b   Nagata, Atsuo ^a  

^a YAMASA CORPORATION   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KANSAI DENRYOKU HOSPITAL   (Japan)

Author keywords

Alanine aminotransferase; Alpha fetoprotein; Hepatocellular carcinoma; Liver cirrhosis; Ornithine carbamoyltransferase

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; LIVER ENZYME; ORNITHINE CARBAMOYLTRANSFERASE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SENSIBILITY;

ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; ORNITHINE CARBAMOYLTRANSFERASE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548131046     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.05.001     Document Type: Article

References (10)

1. Hoofnagle J.H. Course and outcome of hepatitis C. Hepatology 36 (2002) S21-S29
2. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology (1986) 729-738
3. Daniele B., Bencivenga A., Megna A.S., and Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127 (2004) S108-S112
4. Fujiyama S., Morishita T., Hashiguchi O., and Sato T. Plasma abnormal prothrombin (Des-g-Carboxy Prothrombin) as a marker of hepatocellular carcinoma. Cancer 61 (1988) 1621-1628
5. Nomura F., Ishijima M., Kuwa K., Tanaka N., Nakai T., and Ohnishi K. Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma. Am. J. Gastroenterol. 94 (1999) 650-654
6. Sherman K.E. Alanine aminotransferase in clinical practice. Arch. Intern. Med. 151 (1991) 260-265
7. Watanabe Y., Mori S., Fujiyama S., Sato T., and Mori M. Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked immunosorbent assay in patients with liver diseases. Enzyme Protein 48 (1994) 18-26
8. The Japanese Society of Laboratory Medicine. The use of residual samples for methodological study, teaching and research in the clinical laboratory. (in Japanese). Rinsho Byori 50 (2002) 438-439
9. Murayama H., Igarashi M., Mori M., Fukuda Y., Ikemoto M., and Nagata A. A sensitive ELISA for serum ornithine carbamoyltransferase utilizing the enhancement of immunoreactivity at alkaline pH. Clin. Chim. Acta 368 (2006) 125-130
10. Murayama H., Ikemoto M., Fukuda Y., Tsunekawa S., and Nagata A. Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells. Clin. Chim. Acta 380 (2007) 170-174